How Do POC HbA1c Compare Against International Quality Targets?
Can't see this email? View it online
   
  October 9, 2018  
  Hematology  
  The latest hematology news from News Medical  
 

#ALT# How Do POC HbA1c Compare Against International Quality Targets?

Assessing the quality of point of care HbA1c analyzers against international quality targets is an important step towards normalizing their use, their quality has to be as reliable and high quality as their lab counterparts.

Read Full Article Here
 
   Chromatin Remodeling: Mechanisms and ImportanceChromatin Remodeling: Mechanisms and Importance
 
Chromatin remodeling is an important mechanism of regulating eukaryotic gene expression, which makes tightly condensed DNA accessible to various regulatory factors, such as transcription factors and components of DNA replication.
 
   Researchers identify new cancerous cells responsible for acute myeloid leukemia relapseResearchers identify new cancerous cells responsible for acute myeloid leukemia relapse
 
McMaster University researchers have provided evidence of new cancerous cells they have termed cancer regenerating cells, which are responsible for the return of acute myeloid leukemia after remission.
 
 HORIBA Medical’s new HELO fully automated hematology platform installed at Torbay Hospital
 
HORIBA Medical’s new HELO fully automated hematology platform installed at Torbay HospitalHORIBA UK Ltd, Medical announces the first global installation of its new HELO high throughput fully automated hematology platform in Torbay Hospital. The Laboratory there has achieved UKAS ISO 15189 accreditation.
 
 
 Scientists develop first DNA-based test for predicting risk of leukemia relapse
 
Scientists develop first DNA-based test for predicting risk of leukemia relapseA group of Canadian and Korean scientists and physicians have developed the first DNA-based test that allows them to tell which patients will relapse after receiving chemotherapy and a bone marrow transplant, for their acute myeloid leukemia, or AML.
 
 
 New study links stress with biological disease markers in leukemia patients
 
New study links stress with biological disease markers in leukemia patientsPatients with chronic lymphocytic leukemia who feel more stress also have more cancer cells in their blood and elevated levels of three other markers of more advanced disease.
 
 
 Infants face high thrombosis risk
 
Infants face high thrombosis riskRussian scientists have carried out tests to compare the process of blood coagulation in adults and newborns and discovered that the latter face an increased risk of thrombosis.
 
 
 Research shows possibility to postpone cumbersome treatment for low-risk MDS patients
 
Research shows possibility to postpone cumbersome treatment for low-risk MDS patientsIt's possible to postpone the introduction of blood transfusions for an average of 17 months for patients with the low-risk variant of MDS blood cancer, provided they are given erythropoiesis-stimulating agents, which stimulate the body to produce red blood cells, according to a dissertation at Sahlgrenska Academy, Sweden.
 
 
 Biological 'switch' influences whether immature blood cells differentiate into red or white blood cells
 
Biological 'switch' influences whether immature blood cells differentiate into red or white blood cellsJapanese scientists have revealed a biological "switch" that influences whether an immature blood cell would develop into a red blood cell or a subtype of white blood cell called myeloid cells in response to infection or inflammation within the body.
 
 
 Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder
 
Researchers highlight potential therapy for treating rare, deadly blood-clotting disorderIn proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP.